Pregabalin Capsule
Product Images NDC 80425-0160
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig 10
Fig 11
Fig 12
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
This is a description of different studies that assess the efficacy of different doses of an unidentified drug compared to a placebo. The studies are labeled as P Study, E1 Study, and E3 Study. The text includes tables displaying percentages of participants in each group and the doses of the drug administered. The results indicate that some doses of the drug are statistically significant compared to the placebo.*
Fig 7
Fig 9
This appears to be a chart or data table showing the percentage of improvement in pain from various doses of Pregabalin. The chart has five columns, with headings for various dosages of Pregabalin, and a row for percentage of patients improved. The rightmost column shows the percent improvement in pain from baseline.*
Pregabalin 300mg Cap Qty 90 Ndc 80425 0160
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.